Medical Device, Drug & Disease Registries > Clinical Development
The rapid transformation of the biotech and pharmaceutical industries has lead companies to focus on the clinical development of their candidates. The challenge the organizations face is the selection of the optimal strategy for conducting their clinical programs.
Typically, biopharmaceutical companies have had three options:
● Out-licensing their product
● Setting up their own clinical development operations
● Outsourcing clinical development to contract research organizations (CROs)
● A strategic combination of the above
Ascon Health has successfully helped clients understand and evaluate each of the options or a combination of the above options to address their clinical development needs. We have helped our clients successfully execute on the option that best meets their need.